Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.99
Jade Biosciences, Inc. issued 3,214,286 shares of common stock to the Purchaser for $14.00 per Share, aggregate gross proceeds approximately $45 million.
- Security
- common stock
- Shares
- 3,214,286 shares
- Purchaser
- the Purchaser
- Consideration
- $14.00 per Share, aggregate gross proceeds approximately $45 million
Exact text from the filing
On December 13, 2025, Jade Biosciences, Inc. (“Jade” or the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchaser named therein (the “Purchaser”), for the private placement (the “Private Placement”) of 3,214,286 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a price of $14.00 per Share.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Jade Biosciences, Inc. entered into Purchase Agreement with the purchaser named therein (the "Purchaser") valued at approximately $45 million (effective 2025-12-13).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- the purchaser named therein (the "Purchaser")
- Value
- approximately $45 million
- Effective
- 2025-12-13
Exact text from the filing
On December 13, 2025, Jade Biosciences, Inc. ("Jade" or the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with the purchaser named therein (the "Purchaser"), for the private placement (the "Private Placement") of 3,214,286 shares (the "Shares") of the Company's common stock, par value $0.0001 per share (the "Common Stock"), at a price of $14.00 per Share.
View on SEC.gov